Head-to-head · Cost-Efficiency Index
Framework vs WeightlessRx
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Framework
Cost-first shoppers who want doctor-guided treatment selection with a named pharmacy, if you can accept learning the price only after intake.
Visit FrameworkWeightlessRx
Cost-first shoppers who want the lowest advertised sticker price and are willing to commit to a 12-month term to unlock it.
Visit WeightlessRxThe verdict
Framework and WeightlessRx tie on the Cost-Efficiency Index at 45/100, so neither wins outright on the numbers. For most shoppers we'd start with Framework (ranked #463, a hair above #469) — Cost-first shoppers who want doctor-guided treatment selection with a named pharmacy, if you can accept learning the price only after intake. But WeightlessRx is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Framework.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Framework | WeightlessRx |
|---|---|---|
| Cost-Efficiency Index | 45/100 | 45/100 |
| Semaglutide / mo | Not disclosed | Not disclosed |
| Tirzepatide / mo | Not disclosed | Not disclosed |
| Semaglutide / yr (modeled) | — | — |
| Tirzepatide / yr (modeled) | — | — |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #463 | #469 |
Framework
45/100Where the value is
- The compounding pharmacy partner is named, which most of this field does not do
- Treatment selection is doctor-guided rather than a fixed product menu
- US-licensed clinicians and a 503A pharmacy pathway
The tradeoffs
- No monthly medication price is published: the tirzepatide and semaglutide pages carry no price at all, and the homepage advertises a per-week figure for 'GLP-1s' generally rather than a rate for either drug
- The only drug-specific prices anywhere on the site sit on a legacy page — semaglutide at $349 per three months and tirzepatide at $549 per three months
WeightlessRx
45/100Where the value is
- No membership or consultation fees stacked on top of the drug price, unlike bundled-membership competitors
- Free (semaglutide) or priority 24-48hr (tirzepatide) shipping included
- LegitScript-certified with a verification seal linked directly on the site
The tradeoffs
- The advertised $89 (semaglutide) / $133 (tirzepatide) prices require a 12-month commitment — month-to-month billing is nearly double at $174 / $250, a fact easy to miss on a quick skim
- Site never discloses which dose the $89/$133 'starting at' figures actually cover, so real cost at a therapeutic maintenance dose is unclear
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.